The Indian healthcare sector sees emergence of medical networking to revolutionise quality services in remote regions. This is despite the resource and infrastructural constraints leading to the ...

Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of Agamree (vamorolone) in countries where the product is not ...

Capricor Therapeutics, a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced the completion of the submission of its ...

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired Galzin (zinc acetate). “This ...

Expressing its concern over the Department of Expenditure's (DoE) decision to turn down the Department of Pharmaceuticals (DoP)’s proposal for setting up separate National Institutes for Medical ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

The Federal Court of Australia brought an end to the last Roundup case in Australia, closing all pending injury litigation there. The Court granted the plaintiffs’ request to discontinue the Fenton ...

Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced positive topline results with OCS-05 in the phase 2 ACUITY trial, which met the ...

In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 Pro antibodies, KIF23 gene – the same tools used by the world’s leading ...

Hutchmed (China) Limited, an innovative, commercial-stage, biopharmaceutical company, announces that it has entered into two agreements to divest its 45% equity interest in Shanghai Hutchison ...

JCR Pharmaceuticals Co., Ltd., a global specialty pharmaceuticals company, and Modalis Therapeutics Corporation, a forerunner in the field of epigenetic medicine, announced that they have validated ...

Claypond Capital, the family investment office of Manipal Group chairman Ranjan Pai, has roped in former managing director of Wipro-GE Healthcare Shravan Subramanyam to lead its medical technology ...